TY - JOUR T1 - Winners of the ERS Annual Awards 2007 JF - European Respiratory Review JO - EUROPEAN RESPIRATORY REVIEW SP - 65 LP - 66 DO - 10.1183/09059180.00010802 VL - 17 IS - 108 AU - V. C. Moore AU - P. S. Burge Y1 - 2008/06/01 UR - http://err.ersjournals.com/content/17/108/65.abstract N2 - The European Respiratory Review is delighted to publish the second half of the articles from the winners of the European Respiratory Society Annual Awards 2007. The awardees were invited to include the background to their work, how they thought it might be important to respiratory medicine, the aims of the team in which they work and, finally, to include their award-winning abstract. This second section begins with Professor Urs Frey, who won the Romain Pauwels Research Award for his work entitled “Asthma as a nonlinear complex dynamic system: a novel approach to understand the temporal behaviour of chronic asthma and its response to β-agonists” (page 67). By using mathematical methods, he has found that it is possible to calculate the probability or risk that given the current peak expiratory flow (PEF) value, a severe episode of asthma will occur within any time period. Professor Frey is Head of the Division of Paediatric Respiratory Medicine at the University Children’s Hospital in Bern, Switzerland. The research interests of Rodrigo Andres Floto have focused on understanding the basic mechanisms of receptor control of macrophage and dendritic cell function associated with lung infection and autoimmune lung disease. For the Maurizo Vignola Award (page 70), he submitted a paper which examined how dendritic cells are stimulated by mycobacterial heat shock protein through its action on the HIV co-receptor CCR5. Martina Klein presented research entitled “Prevention of pulmonary vascular and myocardial remodeling by the combined tyrosine and serine-/threonine kinase inhibitor, sorafenib, in pulmonary hypertension and right heart failure” (page 72), which won the François Brenot Award. Her work in pre-clinical cardiology research at Bayer Schering Pharma (Wuppertal, Germany) focuses on pulmonary vascular and myocardial remodelling, as well as the validation and discovery of new drugs for pulmonary hypertension and heart failure. Two … ER -